Status:
COMPLETED
The Efficacy of Re-treatment With Sulfadoxine-pyrimethamine in Children
Lead Sponsor:
Bandim Health Project
Conditions:
Malaria, Falciparum
Eligibility:
All Genders
Up to 15 years
Phase:
PHASE4
Brief Summary
Children participating in a study evaluating the efficacy of chloroquine and amodiaquine for the treatment of malaria will, if getting malaria during follow-up, be re-treated with sulfadoxine-pyrimeth...
Detailed Description
The Bandim Health Project studies the efficacy of different treatment regimens for malaria in children. If the included children during follow-up get malaria again they are, according to the recommend...
Eligibility Criteria
Inclusion
- Malaria symptoms plus positive malaria film
- \> 20 parasites per 200 leukocytes
- Treatment failure in a study comparing chloroquine and amodiaquine
- Informed consent
Exclusion
- Stated allergy to sulfadoxine and/or pyrimethamine
Key Trial Info
Start Date :
May 1 2001
Trial Type :
INTERVENTIONAL
End Date :
March 1 2004
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00137553
Start Date
May 1 2001
End Date
March 1 2004
Last Update
March 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Apartado 861, Bissau Region, Guinea-Bissau